Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.

CONCLUSION: Inflammatory rheumatic diseases constitute a risk factor for MRONJ in patients treated with bisphosphonates for osteoporosis. Patients should be counseled accordingly and should be offered dental screening and regular dental check-ups.
PMID: 30796524 [PubMed - as supplied by publisher]

Source: Zeitschrift fur Rheumatologie - February 22, 2019 Category: Rheumatology Authors: Schwaneck EC, Streit A, Krone M, Hartmann S, Müller-Richter U, Kübler AC, Gadeholt O, Schmalzing M, Tony HP, Brands RC Tags: Z Rheumatol Source Type: research